Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-050816

Director acquired 10,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WHITFIELD ROY A Director 2022-09-16 Grant or award +10,200 246,250 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
WHITFIELD ROY A Director 2022-09-16 Grant or award · Stock Option +20,400 20,400 D: show line 2 in the form
Loading xslF345X03/doc4.xml…